Massimo Gion

10.6k citations
141 papers · 8.4k · 4 hit papers · h-index 32

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • HER2/EGFR in Cancer Research 21
    • Pancreatic and Hepatic Oncology Research 14
    • Glycosylation and Glycoproteins Research 16
    • Angiogenesis and VEGF in Cancer 7

Massimo Gion

138 papers receiving 8.3k citations

Massimo Gion's Hit Papers

REporting recommendations for tumor MARKer prognostic studies (REMARK) 2006 · 672 citations
6720+7+14Years since publication50010001.5k

Peers

Massimo Gion
Comparison fields: 5 of 139
  • Cancer Research 2.0k
  • Oncology 2.7k
  • Molecular Biology 2.5k
  • Pathology and Forensic Medicine 551
  • Pulmonary and Respiratory Medicine 913
Replace Sheila E. Taube with:
Sheila E. Taube United States
I. Craig Henderson United States
Percy Ivy United States
Paolo Miccoli Italy
Rossella Elisei Italy
Boštjan Šeruga Canada
Robert Paridaens Belgium
Kristine Broglio United States
Matthew D. Galsky United States
Barbara A. Conley United States
Massimo Gion relative to Sheila E. Taube United States Sheila E. Taube's profile →
Citations per field
00.5×1.5×
Sheila E. Taube · 1×
Citations per year

Countries citing papers authored by Massimo Gion

Since Specialization
Citations

This map shows the geographic impact of Massimo Gion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Gion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Gion more than expected).

Fields of papers citing papers by Massimo Gion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Gion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Gion. The network helps show where Massimo Gion may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Gion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Gion Line = papers co-authored together Massimo Gion links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
Hit paper breakdown →
20051727
2
REporting recommendations for tumour MARKer prognostic studies (REMARK)
Hit paper breakdown →
20051058
3
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Hit paper breakdown →
2006672
4
Reporting Recommendations for Tumor Marker Prognostic Studies
Hit paper breakdown →
2005633
5 2005468
6 1997435
7 2002398
8 2005262
9 2010133
10 2007128
11 2018128
12
Reporting recommendations for tumor marker prognostic studies (remark).
2006124
13 2006109
14
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
199997
15 201690
16 202084
17 202068
18 200167
19 200462
20 200953

About Massimo Gion

Massimo Gion is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 141 papers that have together received 8.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), HER2/EGFR in Cancer Research (21 papers), Glycosylation and Glycoproteins Research (16 papers), Pancreatic and Hepatic Oncology Research (14 papers), Radiomics and Machine Learning in Medical Imaging (10 papers), Breast Cancer Treatment Studies (7 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.7k citations), Molecular Biology (2.5k citations), Pathology and Forensic Medicine (551 citations) and Pulmonary and Respiratory Medicine (913 citations). Massimo Gion has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Sheila E. Taube, Lisa M. McShane, Willi Sauerbrei, Douglas G. Altman, Gary M. Clark, Ruggero Dittadi, Aline S.C. Fabricio, Giampietro Gasparini, Carlo Gatti and Patrizia Boracchi. Their work appears in journals such as The International Journal of Biological Markers, Clinical Chemistry and Laboratory Medicine (CCLM), European Journal of Cancer, Clinical Chemistry and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact